ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

JAGX Jaguar Health Inc

0.17129
0.00639 (3.88%)
Last Updated: 12:03:51
Delayed by 15 minutes

Period:

Draw Mode:

Volume 47,214,818
Bid Price 0.1702
Ask Price 0.1711
News -
Day High 0.175

Low
0.0512

52 Week Range

High
1.22

Day Low 0.1423
Share Name Share Symbol Market Stock Type
Jaguar Health Inc JAGX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00639 3.88% 0.17129 12:03:51
Open Price Low Price High Price Close Price Previous Close
0.1442 0.1423 0.175 0.1649
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
31,574 47,214,818 US$ 0.1549192 US$ 7,314,482 - 0.0512 - 1.22
Last Trade Type Quantity Price Currency
12:03:57 5 US$ 0.1707 USD

Jaguar Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
8.63M 50.76M - 9.76M -41.3M -0.81 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Jaguar Health News

Date Time Source News Article
3/08/202416:00Edgar (US Regulatory)Form 8-K - Current report
3/05/202406:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
3/01/202416:30Edgar (US Regulatory)Form 8-K - Current report
2/16/202415:13Edgar (US Regulatory)Form 8-K - Current report
12/01/202316:25Edgar (US Regulatory)Form 8-K - Current report
11/30/202307:10Edgar (US Regulatory)Form D - Notice of Exempt Offering of Securities
11/14/202320:00PR Newswire (Canada)FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL..
11/08/202316:03Edgar (US Regulatory)Form 8-K - Current report
10/05/202316:03Edgar (US Regulatory)Form 8-K - Current report
9/21/202306:30PR Newswire (Canada)FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA..
8/14/202315:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
8/14/202315:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No JAGX Message Board. Create One! See More Posts on JAGX Message Board See More Message Board Posts

Historical JAGX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.11070.2540.09010.1632899173,514,8900.0605954.73%
1 Month0.08410.2540.06530.127889585,263,5280.08719103.67%
3 Months0.10270.2540.05120.112245260,052,3100.0685966.79%
6 Months0.32270.51440.05120.122874231,025,509-0.15141-46.92%
1 Year0.63011.220.05120.15897516,974,217-0.45881-72.82%
3 Years95.25228.000.051223.758,762,236-95.08-99.82%
5 Years1,286.251,391.250.051279.629,658,745-1,286.08-99.99%

Jaguar Health Description

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.

Your Recent History

Delayed Upgrade Clock